Mammalian Genome

, Volume 14, Issue 9, pp 601–610 | Cite as

Microarray analysis of hepatic gene expression in gallstone-susceptible and gallstone-resistant mice

  • Patricia A. Dyck
  • Farzana Hoda
  • Elizabeth S. Osmer
  • Richard M. Green


Cholesterol gallstone disease affects 40 million Americans, and evidence indicates that there is a genetic component to human gallstone disease. In a mouse model of gallstone formation, where mice are fed a lithogenic diet, QTL analysis has been employed to identify the Lith 1 locus on Chromosome (Chr) 2. In order to identify genes in which the difference in expression is independent of factors other than strain-specific genotype, we employed microarray analysis of hepatic gene expression in gallstone-susceptible (C57L/J) and gallstone-resistant (AKR/J) mice. We observed 57 genes with consistent differential expression between C57L/J and AKR/J mice, including many cytochrome, antioxidant, and lipid peroxidation genes. Analysis of differentially expressed genes identified numerous genes involved in fatty acid metabolism. Northern analysis of selected lipid metabolic genes further confirmed the strain-specific differential expression. Literature searches of common regulatory elements within antioxidant systems identified the nuclear transcription factor Nrf2, which maps to the Lith 1 loci. Hepatic Nrf2 gene and protein expression is also increased in strain AKR/J, compared with C57L/J mice, identifying Nrf2 as a putative Lith 1 gallstone gene. These data indicate that microarray analysis may complement QTL analysis to identify systems of regulation and genotypic differences responsible for polygenic diseases.


Quantitative Trait Locus Analysis Epoxide Hydrolase Gallstone Formation Cholesterol Gallstone Hepatic Gene Expression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was supported by National Institutes of Health grants DK-59580, HD-40027, and a Veteran’s Administration Merit Review Award (R.M. Green).


  1. 1.
    Attili, A,  et al. 1997Factors associated with gallstone disease in the MICOL experience. Multicenter italian study on epidemiology of cholelithiasis.Hepatology26809818PubMedGoogle Scholar
  2. 2.
    Bouchard, G,  et al. 1999High-resolution maps of the murine chromosome.Mamm Genome1010701074CrossRefPubMedGoogle Scholar
  3. 3.
    Buxbaum, JD,  et al. 2002Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.Front Biosci75059Google Scholar
  4. 4.
    Coggan, M,  et al. 1998Structure and organization of the human theta-class glutathione S-transferase and D-dopachrome tautomerase gene complex.Biochem J334617623PubMedGoogle Scholar
  5. 5.
    Dowling, RH 2000Review: pathogenesis of gallstones.Aliment Pharmacol Ther14S23947CrossRefGoogle Scholar
  6. 6.
    Eder, MI,  et al. 1996Reactive oxygen metabolites promote cholesterol crystal formation in model bile: role of lipid peroxidation.Free Radic Biol Med20743749CrossRefPubMedGoogle Scholar
  7. 7.
    Feher, J,  et al. 1998Blazovics A. Oxidative stress in the liver and biliary tract diseases.Scand J Gastroenterol Suppl.2283846CrossRefPubMedGoogle Scholar
  8. 8.
    Fuchs, M,  et al. 2001Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.Hepatology314511459CrossRefGoogle Scholar
  9. 9.
    Green, RM, Beier, D, Gollan, JL 1996Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents.Gastroenterology111193198PubMedGoogle Scholar
  10. 10.
    Gustafsson, U,  et al. 1997The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time.Eur J Clin Invest27387391PubMedGoogle Scholar
  11. 11.
    Johnston, DE, Kaplan, MM 1993Pathogenesis and treatment of gallstones.N Engl J Med328412421CrossRefPubMedGoogle Scholar
  12. 12.
    Kesavulu, MM,  et al. 2002Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients.Diabetes Metab282026PubMedGoogle Scholar
  13. 13.
    Khanuja, B,  et al. 1995Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice.Proc Natl Acad Sci USA9277297733PubMedGoogle Scholar
  14. 14.
    Koudinov, AR,  et al. 2002Cholesterol and Alzheimer’s disease: is there a link?.Neurology581135Google Scholar
  15. 15.
    Kwak, MK,  et al. 2001Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.Mol Med7135145PubMedGoogle Scholar
  16. 16.
    Lammert, F,  et al. 1999Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes.J Lipid Res4020802090PubMedGoogle Scholar
  17. 17.
    Lammert, F, Carey, MC, Paigen, B 2001Chromosomal organization of candidate genes involved in gallstone formation: a murine gallstone map.Gastroenterology120221238PubMedGoogle Scholar
  18. 18.
    LaMorte, WW, Booker, ML, Kay, S 1998Determinants of the selection of phosphatidylcholine molecular species for secretion into bile in the rat.Hepatology28631637CrossRefPubMedGoogle Scholar
  19. 19.
    Leo, MA, Aleynik, SI, Siegel, JH, Kasmin, FE, Aleynik, MK, Lieber, CS 1997.Am J Gastroenterol9220692072PubMedGoogle Scholar
  20. 20.
    Leutner, S,  et al. 2000Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations.Neurosci Lett2928790CrossRefPubMedGoogle Scholar
  21. 21.
    Melov, S,  et al. 1999Mitochondrial disease in superoxide dismutase 2 mutant mice.Proc Natl AcadSci USA96846851CrossRefGoogle Scholar
  22. 22.
    Moschetta, A, vanBerge-Henegouwen, GP, Portincasa, P, Palasciano, G, van Erpecum, KJ 2001Cholesterol crystallization in model biles: effects of bile salt and phospholipid species composition.J Lipid Res4212731281PubMedGoogle Scholar
  23. 23.
    Muller, O,  et al. 2002Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice.Biochem J361673679CrossRefPubMedGoogle Scholar
  24. 24.
    Paigen, B,  et al. 2000Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice.Physiol Genomics45965PubMedGoogle Scholar
  25. 25.
    Pappolla, MA,  et al. 2001Induction of NADPH cytochrome P450 reductase by the Alzheimer beta-protein. Amyloid as a “foreign body”.J Neurochem78121128CrossRefPubMedGoogle Scholar
  26. 26.
    Reiter, R,  et al. 2001Cholelithiasis, oxidative stress, and melatonin.J Pineal Res30127128PubMedGoogle Scholar
  27. 27.
    Rigotti, A,  et al. 2002HDL receptor SR-BI and cholesterol gallstones.Hepatology35240242PubMedGoogle Scholar
  28. 28.
    Sama, C,  et al. 1990Epidemiology and natural history of gallstone disease.Semin Liver Dis10149158Google Scholar
  29. 29.
    Shie, FS,  et al. 2002Diet-induced hypercholesterolemia enhances brain Abeta accumulation in transgenic mice.Neuroreport13455459PubMedGoogle Scholar
  30. 30.
    Shukla, VK,  et al. 1994Lipid peroxidation product in bile from patients with carcinoma of the gallbladder: a preliminary study.J Surg Oncol56258262PubMedGoogle Scholar
  31. 31.
    Siddique, T,  et al. 1996Molecular genetic basis of familial ALS.Neurology47S27S34PubMedGoogle Scholar
  32. 32.
    Simon, JA, Hudes, ES 1998Serum ascorbic acid and other correlates of gallbladder disease among US adults.Am J Public Health8812081212PubMedGoogle Scholar
  33. 33.
    Thimmulappa, RK,  et al. 2002Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray.Cancer Res6251965203PubMedGoogle Scholar
  34. 34.
    Worthington, HV, Hunt, LP, McCloy, RF, Maclennan, I, Braganza, JM 1997A pilot study of antioxidant intake in patients with cholesterol gallstones.Nutrition131181127CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 2003

Authors and Affiliations

  • Patricia A. Dyck
    • 1
    • 2
  • Farzana Hoda
    • 3
  • Elizabeth S. Osmer
    • 3
  • Richard M. Green
    • 3
    • 4
  1. 1.Center for Genetic MedicineNorthwestern University, Chicago, ILUSA
  2. 2.Department of Computer ScienceNorthwestern University, Chicago, ILUSA
  3. 3.Department of Medicine and Division of HepatologyNorthwestern University Feinberg School of Medicine, Searle 10-541, 303 E. Chicago Avenue, Chicago, IL 60611USA
  4. 4.VAMC-Lakeside Division, Chicago, ILUSA

Personalised recommendations